Diversify Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Diversify Advisory Services's BMY Position: Q1 2026 in Review
Diversify Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 46% in Q1 2026, selling an estimated $331K and leaving 6,608 shares worth $381K. The position accounts for 0.06% of the portfolio, ranked #140.
Diversify Advisory Services first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.22M in Q1 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Diversify Advisory Services held 6,608 shares of Bristol-Myers Squibb worth $381K as of Q1 2026.
- Diversify Advisory Services sold 5,676 Bristol-Myers Squibb shares in Q1 2026, an estimated $331K.
- Bristol-Myers Squibb made up 0.06% of Diversify Advisory Services's portfolio in Q1 2026, its #140 holding.
- Diversify Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
- Diversify Advisory Services's Bristol-Myers Squibb position peaked at $1.22M in Q1 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Diversify Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.